{"id":"https://openalex.org/W2005464092","doi":"https://doi.org/10.1016/j.breast.2009.05.004","title":"Improving the therapeutic index of anthracycline chemotherapy: Focus on liposomal doxorubicin (Myocet\u2122)","display_name":"Improving the therapeutic index of anthracycline chemotherapy: Focus on liposomal doxorubicin (Myocet\u2122)","publication_year":2009,"publication_date":"2009-08-01","ids":{"openalex":"https://openalex.org/W2005464092","doi":"https://doi.org/10.1016/j.breast.2009.05.004","mag":"2005464092","pmid":"https://pubmed.ncbi.nlm.nih.gov/19656681"},"language":"en","primary_location":{"id":"doi:10.1016/j.breast.2009.05.004","doi":"https://doi.org/10.1016/j.breast.2009.05.004","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.breast.2009.05.004","pdf_url":"http://www.thebreastonline.com/article/S0960977609000630/pdf","source":{"id":"https://openalex.org/S181123643","display_name":"The Breast","issn_l":"0960-9776","issn":["0960-9776","1532-3080"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Breast","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2005464092"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.thebreastonline.com/article/S0960977609000630/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109528214","display_name":"Robert C. Leonard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801748203","display_name":"Hammersmith Hospital","ror":"https://ror.org/05jg8yp15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2801748203"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"R.C.F. Leonard","raw_affiliation_strings":["Imperial College NHS Trust, Hammersmith Hospital, Du Cane Road, London W12 OHS, UK. rleonard@imperial.ac.uk","Imperial College NHS Trust, Hammersmith Hospital, Du Cane Road, London W12 OHS, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imperial College NHS Trust, Hammersmith Hospital, Du Cane Road, London W12 OHS, UK. rleonard@imperial.ac.uk","institution_ids":["https://openalex.org/I2801748203"]},{"raw_affiliation_string":"Imperial College NHS Trust, Hammersmith Hospital, Du Cane Road, London W12 OHS, UK","institution_ids":["https://openalex.org/I2801748203"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101525361","display_name":"S. Williams","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800526087","display_name":"Singleton Hospital","ror":"https://ror.org/02ab2dg68","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1294711689","https://openalex.org/I2800526087"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S. Williams","raw_affiliation_strings":["Singleton Hospital, Swansea, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Singleton Hospital, Swansea, UK","institution_ids":["https://openalex.org/I2800526087"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044445275","display_name":"A. Tulpule","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]},{"id":"https://openalex.org/I4210117038","display_name":"USC Norris Comprehensive Cancer Center","ror":"https://ror.org/01nmyfr60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800154431","https://openalex.org/I4210117038"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"A. Tulpule","raw_affiliation_strings":["University of Southern California, USC/Norris Comprehensive Cancer Center, Los Angeles, California, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Southern California, USC/Norris Comprehensive Cancer Center, Los Angeles, California, CA, USA","institution_ids":["https://openalex.org/I1174212","https://openalex.org/I4210117038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110871826","display_name":"A. M. Levine","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]},{"id":"https://openalex.org/I4210117038","display_name":"USC Norris Comprehensive Cancer Center","ror":"https://ror.org/01nmyfr60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800154431","https://openalex.org/I4210117038"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"A.M. Levine","raw_affiliation_strings":["University of Southern California, USC/Norris Comprehensive Cancer Center, Los Angeles, California, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Southern California, USC/Norris Comprehensive Cancer Center, Los Angeles, California, CA, USA","institution_ids":["https://openalex.org/I1174212","https://openalex.org/I4210117038"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110611854","display_name":"S. Oliveros","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801748203","display_name":"Hammersmith Hospital","ror":"https://ror.org/05jg8yp15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2801748203"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"S. Oliveros","raw_affiliation_strings":["Imperial College NHS Trust, Hammersmith Hospital, Du Cane Road, London W12 OHS, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imperial College NHS Trust, Hammersmith Hospital, Du Cane Road, London W12 OHS, UK","institution_ids":["https://openalex.org/I2801748203"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5044445275","https://openalex.org/A5109528214","https://openalex.org/A5110611854","https://openalex.org/A5110871826"],"corresponding_institution_ids":["https://openalex.org/I1174212","https://openalex.org/I2801748203","https://openalex.org/I4210117038"],"apc_list":{"value":3200,"currency":"USD","value_usd":3200},"apc_paid":{"value":3200,"currency":"USD","value_usd":3200},"fwci":1.679,"has_fulltext":false,"cited_by_count":265,"citation_normalized_percentile":{"value":0.8550543,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"18","issue":"4","first_page":"218","last_page":"224"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.7958999872207642,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.7958999872207642,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.07580000162124634,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.07440000027418137,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/liposomal-doxorubicin","display_name":"liposomal doxorubicin","score":0.9919999837875366},{"id":"https://openalex.org/keywords/anthracycline-induced-cardiotoxicity","display_name":"anthracycline cardiotoxicity","score":0.9169999957084656},{"id":"https://openalex.org/keywords/cumulative-dose","display_name":"cumulative dose","score":0.36899998784065247},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.8889999985694885},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.8050000071525574},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/epirubicin","display_name":"epirubicin","score":0.9760000109672546},{"id":"https://openalex.org/keywords/cardiac-safety","display_name":"cardiac safety","score":0.675000011920929},{"id":"https://openalex.org/keywords/therapeutic-index","display_name":"therapeutic index","score":0.8050000071525574}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.946830153465271},{"id":"https://openalex.org/C2778233292","wikidata":"https://www.wikidata.org/wiki/Q2118956","display_name":"Cardiotoxicity","level":3,"score":0.9279165267944336},{"id":"https://openalex.org/C2780835546","wikidata":"https://www.wikidata.org/wiki/Q425122","display_name":"Epirubicin","level":4,"score":0.8949373960494995},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.8198472261428833},{"id":"https://openalex.org/C2776802502","wikidata":"https://www.wikidata.org/wiki/Q417589","display_name":"Anthracycline","level":4,"score":0.7354027032852173},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.6725585460662842},{"id":"https://openalex.org/C19831878","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Therapeutic index","level":3,"score":0.6706613302230835},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6313721537590027},{"id":"https://openalex.org/C151032500","wikidata":"https://www.wikidata.org/wiki/Q5194182","display_name":"Cumulative dose","level":2,"score":0.5809555649757385},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5452407598495483},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4860127866268158},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.46575766801834106},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.41976919770240784},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3829807937145233},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3774738907814026},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.27230942249298096},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.1598447561264038}],"mesh":[{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000903","descriptor_name":"Antibiotics, Antineoplastic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000903","descriptor_name":"Antibiotics, Antineoplastic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000903","descriptor_name":"Antibiotics, Antineoplastic","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D006321","descriptor_name":"Heart","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006333","descriptor_name":"Heart Failure","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008081","descriptor_name":"Liposomes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015251","descriptor_name":"Epirubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016276","descriptor_name":"Ventricular Function","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D053475","descriptor_name":"Receptor-Interacting Protein Serine-Threonine Kinase 2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.breast.2009.05.004","doi":"https://doi.org/10.1016/j.breast.2009.05.004","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.breast.2009.05.004","pdf_url":"http://www.thebreastonline.com/article/S0960977609000630/pdf","source":{"id":"https://openalex.org/S181123643","display_name":"The Breast","issn_l":"0960-9776","issn":["0960-9776","1532-3080"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Breast","raw_type":"journal-article"},{"id":"pmid:19656681","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19656681","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast (Edinburgh, Scotland)","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.breast.2009.05.004","doi":"https://doi.org/10.1016/j.breast.2009.05.004","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.breast.2009.05.004","pdf_url":"http://www.thebreastonline.com/article/S0960977609000630/pdf","source":{"id":"https://openalex.org/S181123643","display_name":"The Breast","issn_l":"0960-9776","issn":["0960-9776","1532-3080"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Breast","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":65,"referenced_works":["https://openalex.org/W82259717","https://openalex.org/W125325141","https://openalex.org/W1212503504","https://openalex.org/W1796787464","https://openalex.org/W1804680040","https://openalex.org/W1828224642","https://openalex.org/W1833330468","https://openalex.org/W1911376378","https://openalex.org/W1964641698","https://openalex.org/W1970327435","https://openalex.org/W1977939651","https://openalex.org/W1978585178","https://openalex.org/W1979350780","https://openalex.org/W1982230933","https://openalex.org/W1987593270","https://openalex.org/W1996530624","https://openalex.org/W1996653259","https://openalex.org/W1998677697","https://openalex.org/W1999672808","https://openalex.org/W2014325593","https://openalex.org/W2022361916","https://openalex.org/W2027735831","https://openalex.org/W2029667659","https://openalex.org/W2037501592","https://openalex.org/W2041474575","https://openalex.org/W2050319891","https://openalex.org/W2058337944","https://openalex.org/W2066048575","https://openalex.org/W2070825008","https://openalex.org/W2072271765","https://openalex.org/W2073912429","https://openalex.org/W2084229409","https://openalex.org/W2089448457","https://openalex.org/W2091899293","https://openalex.org/W2094448828","https://openalex.org/W2096593771","https://openalex.org/W2100276570","https://openalex.org/W2104337757","https://openalex.org/W2106926141","https://openalex.org/W2111922520","https://openalex.org/W2115432999","https://openalex.org/W2116164394","https://openalex.org/W2123819451","https://openalex.org/W2124126928","https://openalex.org/W2129765581","https://openalex.org/W2133756116","https://openalex.org/W2134260774","https://openalex.org/W2140172581","https://openalex.org/W2146035745","https://openalex.org/W2146384083","https://openalex.org/W2149908785","https://openalex.org/W2157255328","https://openalex.org/W2159351246","https://openalex.org/W2159845849","https://openalex.org/W2159905203","https://openalex.org/W2162387248","https://openalex.org/W2164159671","https://openalex.org/W2167657359","https://openalex.org/W2177367074","https://openalex.org/W2295658630","https://openalex.org/W2318605753","https://openalex.org/W4240034311","https://openalex.org/W4254723667","https://openalex.org/W4255762755","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2034665844","https://openalex.org/W2144606873","https://openalex.org/W2053723794","https://openalex.org/W2170837122","https://openalex.org/W2026172548","https://openalex.org/W2327509076","https://openalex.org/W1890069400","https://openalex.org/W1911376378","https://openalex.org/W1505216143","https://openalex.org/W1978585178"],"abstract_inverted_index":{"Anthracyclines":[0],"are":[1,64],"valuable":[2],"cytotoxic":[3],"agents":[4,79],"in":[5,59,75,99,132],"cancer":[6,62],"treatment.":[7],"However,":[8],"their":[9],"usefulness":[10],"is":[11,32,93,137],"limited":[12],"by":[13],"cumulative":[14,38,100,135],"dose-dependent":[15],"cardiotoxicity":[16,136],"that":[17,69,87,96,103],"may":[18,42,119],"manifest":[19],"as":[20,81,140],"life-threatening":[21],"congestive":[22],"heart":[23],"failure.":[24],"To":[25],"avoid":[26],"cardiotoxicity,":[27],"the":[28,104],"use":[29,145],"of":[30,54,90,97,143],"doxorubicin":[31,57,92,113,118],"typically":[33],"capped":[34],"at":[35,114],"a":[36,121,138],"safe":[37],"dose.":[39],"Liposomal":[40,117],"formulations":[41],"reduce":[43],"cardiac":[44,73,88],"risks":[45],"whilst":[46],"maintaining":[47],"anti-cancer":[48,110],"efficacy.":[49],"Efficacy":[50],"and":[51,72,83],"safety":[52,89],"studies":[53,68,131],"non-pegylated":[55],"liposomal":[56,91],"(NPLD)":[58],"metastatic":[60],"breast":[61],"(MBC)":[63],"reviewed,":[65],"along":[66],"with":[67,77,146],"examine":[70],"efficacy":[71,111],"tolerability":[74],"combination":[76],"newer":[78],"such":[80],"paclitaxel":[82],"trastuzumab.":[84],"These":[85],"show":[86],"similar":[94,109],"to":[95,112],"epirubicin":[98],"dose,":[101],"but":[102],"formulation,":[105],"unlike":[106],"epirubicin,":[107],"has":[108],"equimolar":[115],"doses.":[116],"have":[120],"better":[122],"therapeutic":[123],"index":[124],"than":[125],"non-liposomal":[126],"anthracyclines.":[127],"This":[128],"justifies":[129],"further":[130],"patients":[133],"where":[134],"concern,":[139],"does":[141],"study":[142],"its":[144],"other":[147],"potentially":[148],"cardiotoxic":[149],"agents.":[150]},"counts_by_year":[{"year":2026,"cited_by_count":10},{"year":2025,"cited_by_count":15},{"year":2024,"cited_by_count":23},{"year":2023,"cited_by_count":27},{"year":2022,"cited_by_count":20},{"year":2021,"cited_by_count":21},{"year":2020,"cited_by_count":12},{"year":2019,"cited_by_count":14},{"year":2018,"cited_by_count":12},{"year":2017,"cited_by_count":19},{"year":2016,"cited_by_count":15},{"year":2015,"cited_by_count":16},{"year":2014,"cited_by_count":13},{"year":2013,"cited_by_count":14},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-15T12:55:33.944570","created_date":"2016-06-24T00:00:00"}
